Trogocytosis of HER2 overexpressing human breast cancer cell lines may induce its dormancy without depending on HER family signal

被引：1
|
作者：
Aratake, Junichi [1 ]
Suzuki, Eiji [1 ]
Uehiro, Natsue [1 ]
Nishie, Mariko [1 ]
Kawaguchi, Kosuke [1 ]
Sato, Fumiaki [1 ]
Toi, Masakazu [1 ]
机构：
[1] Kyoto Univ Hosp, Kyoto 606, Japan
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-1092
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1092
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Proteomic characterization of Her2/neu-overexpressing breast cancer cells
    Chen, Hexin
    Pimienta, Genaro
    Gu, Yiben
    Sun, Xu
    Hu, Jianjun
    Kim, Min-Sik
    Chaerkady, Raghothama
    Gucek, Marjan
    Cole, Robert N.
    Sukumar, Saraswati
    Pandey, Akhilesh
    PROTEOMICS, 2010, 10 (21) : 3800 - 3810
  • [42] Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
    Yang, Yi-ling
    Fan, Yu
    Lang, Rong-gang
    Gu, Feng
    Ren, Mei-Jing
    Zhang, Xin-Min
    Yin, Dong
    Fu, Li
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (03) : 1095 - 1102
  • [43] Proteomic characterization of Her2/neu-overexpressing breast cancer cells
    Chen, Hexin
    Pimienta, Genaro
    Gu, Yiben
    Sun, Xu
    Hu, Jianjun
    Kim, Min-Sik
    Chaerkady, Raghothama
    Gucek, Marjan
    Cole, Robert N.
    Sukumar, Saraswati
    Pandey, Akhilesh
    PROTEOMICS CLINICAL APPLICATIONS, 2011, 5 (3-4) : 201 - 201
  • [44] Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance
    Yi-ling Yang
    Yu Fan
    Rong-gang Lang
    Feng Gu
    Mei-Jing Ren
    Xin-Min Zhang
    Dong Yin
    Li Fu
    Breast Cancer Research and Treatment, 2012, 134 : 1095 - 1102
  • [45] Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer
    Kunal S. Taskar
    Vinay Rudraraju
    Rajendar K. Mittapalli
    Ramakrishna Samala
    Helen R. Thorsheim
    Julie Lockman
    Brunilde Gril
    Emily Hua
    Diane Palmieri
    Joseph W. Polli
    Stephen Castellino
    Stephen D. Rubin
    Paul R. Lockman
    Patricia S. Steeg
    Quentin R. Smith
    Pharmaceutical Research, 2012, 29 : 770 - 781
  • [46] A Fab of trastuzumab to treat HER2 overexpressing breast cancer brain metastases
    Angeli, Eurydice
    Paris, Justine
    Le Tilly, Olivier
    Desvignes, Celine
    Gapihan, Guillaume
    Boquet, Didier
    Pamoukdjian, Frederic
    Hamdan, Diaddin
    Rigal, Marthe
    Poirier, Florence
    Lutomski, Didier
    Azibani, Feriel
    Mebazaa, Alexandre
    Herbet, Amaury
    Mabondzo, Aloise
    Falgarone, Geraldine
    Janin, Anne
    Paintaud, Gilles
    Bousquet, Guilhem
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [47] Human Domain Antibodies to Conserved Epitopes on HER2 Potently Inhibit Growth of HER2-Overexpressing Human Breast Cancer Cells In Vitro
    Wang, Hongqian
    Wang, Yanping
    Xiao, Zuoxiang
    Li, Wei
    Dimitrov, Dimiter S.
    Chen, Weizao
    ANTIBODIES, 2019, 8 (01)
  • [48] A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer
    Menyhart, Otilia
    Santarpia, Libero
    Gyorffy, Balazs
    CURRENT CANCER DRUG TARGETS, 2015, 15 (08) : 665 - 683
  • [49] Human HER2 overexpressing mouse breast cancer cell lines derived from MMTV.f.HuHER2 mice: characterization and use in a model of metastatic breast cancer
    Park, Sunju
    Nedrow, Jessie R.
    Josefsson, Anders
    Sgouros, George
    ONCOTARGET, 2017, 8 (40) : 68071 - 68082
  • [50] A class of genes in the HER2 regulon that is poised for transcription in breast cancer cell lines and expressed in human breast tumors
    Rahmatpanah, Farah B.
    Jia, Zhenyu
    Chen, Xin
    Char, Jessica E.
    Men, Bozhao
    Franke, Anna-Clara
    Jones, Frank E.
    McClelland, Michael
    Mercola, Dan
    ONCOTARGET, 2015, 6 (02) : 1286 - 1301
12345